Maham Fatima
Wed, March 4, 2026 astatine 10:40 AM CST 2 min read
This milestone follows the Breakthrough Therapy designation granted successful precocious 2025, with the institution remaining connected way to initiate the Phase 3 programme successful the 2nd 4th of 2026. The Phase 3 programme consists of 2 parallel pivotal studies, ReConnection 1 and ReConnection 2, followed by a 52-week open-label hold to measure semipermanent information and individualized retreatment. ReConnection 1 volition measure azygous doses of 8 mg and 4 mg against a placebo to qualify the dose-response relationship, portion ReConnection 2 volition analyse a two-dose induction exemplary connected Day 1 and Day 15.
Designed to acceptable wrong existing interventional psychiatry workflows, BPL-003 aims to connection a accelerated and durable attraction enactment with an astir two-hour in-clinic experience. AtaiBeckley Inc. (NASDAQ:ATAI) believes that this exemplary addresses important barriers for patients and providers by requiring lone a fewer treatments per year.
AtaiBeckley Inc. (NASDAQ:ATAI) is simply a clinical-stage biopharmaceutical institution that researches, develops, and commercializes intelligence wellness treatments successful the US, Germany, and Canada.
While we admit the imaginable of ATAI arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 12 Most Promising Micro-Cap Stocks According to Analysts.
Disclosure: None. Follow Insider Monkey connected Google News.

1 hour ago
3





English (CA) ·
English (US) ·
Spanish (MX) ·